EP3840753
Mígalastat til notkunar í aðferðum til meðhöndlunar á Fabrys-sjúkdómi í sjúklingum sem hafa stökkbreytingu í GLA geninu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.1.2019EP published:
24.7.2024EP application number:
19703514.0
EP translation filed:
21.10.2024Grant published:
15.11.2024EPO information:
European Patent Register
Max expiry date:
15.1.2039Expiry date:
15.1.2027Next due date:
31.1.2027
Title in English:
MIGALASTAT FOR USE IN METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING A MUTATION IN THE GLA GENELanguage of the patent:
English
Timeline
Today
16.1.2019EP application
24.7.2024EP Publication
21.10.2024Translation submitted
15.11.2024Registration published
15.1.2027Expires
Owner
Name:
Amicus Therapeutics, Inc.Address:
3675 Market Street, Philadelphia, PA 19104, US
Inventor
Name:
BENJAMIN, ElfridaAddress:
Cranbury, New Jersey 08512, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862719962 PDate:
20.8.2018Country:
US
Classification
Categories:
A61K 31/445, A61P 3/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 10.12.2024
Expires: 15.1.2026
Payer: Árnason Faktor ehf.
Number: 8
Paid: 13.1.2026
Expires: 15.1.2027
Payer: Árnason Faktor ehf.